[Management of pain relief in dental medicine.]
This script gives a pragmatic advice for dentists on pain control and anti-inflammation treatment considering current literature and state of the art of analgesic treatment. Naproxen seems to be the feasible anti-inflammatory painkiller as it has a lower cardio-vascular risk profile compared to other NSAID. The higher gastrointestinal bleeding risk can be mitigated using proton-pump inhibitors. Additionally, the duration of the drug effect of about 1215 hours allows excellent patient compliance and comfort in comparison to other NSAID.
Klinik und Poliklinik für Mund-, Kiefer- und Gesichtschirurgie, Zentrum für Zahnmedizin der Universität Zürich, Zürich , Switzerland.
Claudio
C
Rostetter
Heinz-Theo
HT
Lübbers
Philipp
P
Metzler
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D003729:Dental Care; D006801:Humans; D009288:Naproxen / Q000009:adverse effects / Q000627:therapeutic use; D059408:Pain Management / Q000379:methods*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D009288:Naproxen
nichtsteroidales Antirheumatikum; Naproxen; Analgesie